Protein Kinase Expression of the AKT/mTOR Signaling Pathway in Peripheral Mononuclear Cells of Schizophrenia

Anastasiia S Boiko1, Ekaterina V Mikhalitskaya1, Elena G Kornetova1

  • 1Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Aleutskaya Str., 4, 634014 Tomsk, Russia.

Neurosci
|November 24, 2025
PubMed

Insights

Dysfunctional AKT/mTOR signaling, particularly increased AKT1 and p70S6K expression, is linked to schizophrenia pathogenesis. This suggests signaling pathways as potential targets for treating this mental disorder.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Schizophrenia pathogenesis requires further investigation into molecular signaling pathways.
  • The AKT/mTOR signaling cascade's role in mental disorders is not fully understood.

Purpose of the Study:

  • To investigate the expression of the AKT/mTOR signaling pathway in peripheral mononuclear cells (PMCs) of schizophrenia patients.
  • To correlate kinase expression with clinical characteristics of schizophrenia.

Main Methods:

  • Multiplex analysis was used to determine the expression of AKT1, mTOR, p70S6K, GSK3-α, and GSK3-β in PMCs.
  • Statistical analysis was performed using SPSS with a significance level of 0.05.
  • The study included 58 schizophrenia patients (F20) and 60 healthy controls.

Main Results:

  • Significantly increased expression of AKT1 (p=0.006) and p70S6K (p=0.001) was observed in the PMCs of schizophrenia patients.
  • Elevated GSK3-α (p=0.019) and GSK3-β (p=0.018) expression was found in patients with schizophrenia duration exceeding 5 years.

Conclusions:

  • The AKT/mTOR signaling cascade appears to play a significant role in the pathogenesis of schizophrenia.
  • These signaling pathways may serve as crucial targets for novel pharmacotherapy, prognosis, and diagnostic approaches in mental disorders.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K